I wouldn't expect another one till next year. They have a few presentations and just may find someone to help with the trials. Landing a decent CEO would be the real ticket over the next couple of months.
Who wouldn't want to be a part of their products moving forward?
(0)
(0)
Theriva Biologics, Inc. (TOVX) Stock Research Links